Cardiovascular Sales Help Raise Response Biomedical's Q2 Revenues 10 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Response Biomedical today said that revenues in the second quarter increased 10 percent year over year with particular strength in cardiovascular product sales.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.